Postherpetic Neuralgia Meeting in Fort Worth

Thoughtfully Engineered for Your Adult Patients With Postherpetic Neuralgia (PHN)

Don’t miss this important educational opportunity to learn more about advanced PROdrug technology!

Program Description

Join your colleagues for this educational presentation focusing on the disease state of postherpetic neuralgia (PHN). We will discuss concerns in managing your adult patients with PHN while examining how a PROdrug providing dose-proportional bioavailability and sustained, predictable absorption may provide relief. We will further discuss the clinical trial designs, efficacy results, and safety profile information related to the use of HORIZANT. The presentation will be followed by a live question and answer session.

Program Objectives

• Upon completion of this program, participants should be better able to
• Discuss the diagnosis and medical management of adult patients with PHN
• Explain how HORIZANT utilizes a thoughtfully engineered transported PROdrug technology to support predictable absorption and dose- proportional bioavailability
• Understand the barriers of absorption and why HORIZANT is not interchangeable with other gabapentin products
• Interpret the clinical evidence establishing the efficacy of HORIZANT in adult PHN patients
• Review the clinical safety profile of HORIZANT when discussing tolerability and dosing with appropriate adult PHN patients